EverQuote, Inc. (NASDAQ: EVER) disclosed a small sale by its chief financial officer when Joseph Sanborn executed a transaction on April 2, 2026, selling 650 shares of Class A Common Stock at $14.42 per share, for a total of $9,373. The company’s shares are trading near a 52-week low of $13.93 and have declined 44% year-to-date, even as InvestingPro’s Fair Value analysis indicates the stock is presently undervalued.
The sale was reported on a Form 4 filed with the Securities and Exchange Commission and was carried out pursuant to a pre-arranged Rule 10b5-1 trading plan. According to the filing, the trades were intended to cover tax obligations that arose from the vesting of restricted stock units on April 1, 2026.
In a related internal transaction on April 1, 2026, EverQuote withheld 8,603 shares from Sanborn’s compensation to satisfy tax liabilities connected to the RSU vesting. Those withheld shares were valued at $14.74 each, amounting to $126,808 in total.
After these actions, Sanborn’s direct ownership stands at 357,660 shares of EverQuote’s Class A Common Stock. He also has indirect holdings of 1,365 shares in each of two UTMA accounts established for his children, as reflected in the filing.
InvestingPro assigns EverQuote a "GREAT" financial health score, noting the company carries more cash than debt and delivered profitability over the last twelve months. The firm’s recent operating performance included a strong fourth-quarter 2025 financial report: earnings per share of $1.54 versus a consensus forecast of $0.36, representing a 327.78% EPS surprise. Revenue for the quarter reached $195.3 million, beating expectations of $176.82 million and registering a 10.45% surprise.
Despite those outsized results, several analyst groups adjusted their near-term outlooks for EverQuote. Craig-Hallum lowered its price target to $20 from $33, citing uncertainty about how insurance carriers will approach the market. Needham trimmed its target to $25 from $40, pointing to a slower outlook for the first quarter despite strong fourth-quarter results. Canaccord Genuity also reduced its target, to $28 from $33, referencing the company’s guidance for the upcoming quarter. All three firms maintained Buy ratings on the shares, producing a mix of optimism about the company’s performance and caution about growth prospects ahead.
The insider transactions and updated analyst views highlight a market balancing act: management-level actions to meet tax obligations tied to compensation, robust recent profitability and revenue, and analyst recalibrations driven by forward guidance and carrier behavior. The filings show the CFO’s sales were structured and connected to compensation vesting rather than ad hoc dispositions.
Additional context in filings and metrics is limited to the information disclosed above.